123 related articles for article (PubMed ID: 33122156)
1. Emodin inhibited NADPH-quinone reductase competitively and induced cytotoxicity in rat primary hepatocytes.
Shukla V; Asthana S; Yadav S; Rajput VS; Tripathi A
Toxicon; 2020 Dec; 188():117-121. PubMed ID: 33122156
[TBL] [Abstract][Full Text] [Related]
2. Emodin inhibited NADPH-quinone reductase via competitive mode of inhibition and induced cytotoxicity in rat primary hepatocytes.
Shukla V; Asthana S; Yadav S; Rajput VS; Tripathi A
Toxicon; 2020 Oct; ():. PubMed ID: 34756840
[TBL] [Abstract][Full Text] [Related]
3. Role of anthraquinones in Cassia occidentalis induced hepato-myo-encephalopathy.
Shukla V; Asthana S; Singh S; Anurag Tripathi
J Ethnopharmacol; 2021 Mar; 267():113431. PubMed ID: 33011371
[TBL] [Abstract][Full Text] [Related]
4. Activity-guided chemo toxic profiling of Cassia occidentalis (CO) seeds: detection of toxic compounds in body fluids of CO-exposed patients and experimental rats.
Panigrahi GK; Ch R; Mudiam MK; Vashishtha VM; Raisuddin S; Das M
Chem Res Toxicol; 2015 Jun; 28(6):1120-32. PubMed ID: 25915165
[TBL] [Abstract][Full Text] [Related]
5. Interaction of anthraquinones of
Panigrahi GK; Verma N; Singh N; Asthana S; Gupta SK; Tripathi A; Das M
Toxicol Rep; 2018; 5():164-172. PubMed ID: 29326881
[TBL] [Abstract][Full Text] [Related]
6. Quinoneimines as substrates for quinone reductase (NAD(P)H: (quinone-acceptor)oxidoreductase) and the effect of dicumarol on their cytotoxicity.
Powis G; See KL; Santone KS; Melder DC; Hodnett EM
Biochem Pharmacol; 1987 Aug; 36(15):2473-9. PubMed ID: 2440444
[TBL] [Abstract][Full Text] [Related]
7. Characterization of NADPH-dependent ubiquinone reductase activity in rat liver cytosol: effect of various factors on ubiquinone-reducing activity and discrimination from other quinone reductases.
Takahashi T; Okamoto T; Kishi T
J Biochem; 1996 Feb; 119(2):256-63. PubMed ID: 8882715
[TBL] [Abstract][Full Text] [Related]
8. Mitomycin C is not metabolized by but is an inhibitor of human kidney NAD(P)H: (quinone-acceptor)oxidoreductase.
Schlager JJ; Powis G
Cancer Chemother Pharmacol; 1988; 22(2):126-30. PubMed ID: 3136941
[TBL] [Abstract][Full Text] [Related]
9. A novel plasma membrane quinone reductase and NAD(P)H:quinone oxidoreductase 1 are upregulated by serum withdrawal in human promyelocytic HL-60 cells.
Forthoffer N; Gómez-Díaz C; Bello RI; Burón MI; Martín SF; Rodríguez-Aguilera JC; Navas P; Villalba JM
J Bioenerg Biomembr; 2002 Jun; 34(3):209-19. PubMed ID: 12171070
[TBL] [Abstract][Full Text] [Related]
10. Studies of the ferricyanide reductase activities of the mitochondrial reduced nicotinamide adenine dinucleotide-ubiquinone reductase (complex I) utilizing arylazido-beta-alanyl NAD+ and arylazido-beta-alanyl NADP+.
Chen S; Guillory RJ
J Bioenerg Biomembr; 1985 Feb; 17(1):33-49. PubMed ID: 3921531
[TBL] [Abstract][Full Text] [Related]
11. Histochemical detection of quinone reductase activity in situ using LY 83583 reduction and oxidation.
Murphy TH; So AP; Vincent SR
J Neurochem; 1998 May; 70(5):2156-64. PubMed ID: 9572303
[TBL] [Abstract][Full Text] [Related]
12. NAD(P)H: quinone oxidoreductase (DT-diaphorase) in chick embryo liver. Comparison to activity in rat and guinea pig liver and differences in co-induction with 7-ethoxyresorufin deethylase by 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Spencer CB; Rifkind AB
Biochem Pharmacol; 1990 Jan; 39(2):327-35. PubMed ID: 2105732
[TBL] [Abstract][Full Text] [Related]
13. The metabolism of 9-chloro-β-lapachone and its effects in isolated hepatocytes. The involvement of NAD(P)H:quinone oxidoreductase 1 (NQO1).
Fernandez Villamil SH; Carrizo PH; Di Rosso ME; Molina Portela MP; Dubin M
Chem Biol Interact; 2012 Dec; 200(2-3):84-91. PubMed ID: 23047025
[TBL] [Abstract][Full Text] [Related]
14. Retention of NADPH-linked quinone reductase activity in an aldo-keto reductase following mutation of the catalytic tyrosine.
Schlegel BP; Ratnam K; Penning TM
Biochemistry; 1998 Aug; 37(31):11003-11. PubMed ID: 9692994
[TBL] [Abstract][Full Text] [Related]
15. Photodependent inhibition of rat liver NAD(P)H:quinone acceptor oxidoreductase by (A)-2-azido-NAD+ and (A)-8-azido-NAD.
Deng PS; Zhao SH; Iyanagi T; Chen SA
Biochemistry; 1991 Jul; 30(28):6942-8. PubMed ID: 1906347
[TBL] [Abstract][Full Text] [Related]
16. Effect of dicumarol, a Nad(P)h: quinone acceptor oxidoreductase 1 (DT-diaphorase) inhibitor on ubiquinone redox cycling in cultured rat hepatocytes.
Kishi T; Takahashi T; Mizobuchi S; Mori K; Okamoto T
Free Radic Res; 2002 Apr; 36(4):413-9. PubMed ID: 12069105
[TBL] [Abstract][Full Text] [Related]
17. Hepatic low-level chemiluminescence during redox cycling of menadione and the menadione-glutathione conjugate: relation to glutathione and NAD(P)H:quinone reductase (DT-diaphorase) activity.
Wefers H; Sies H
Arch Biochem Biophys; 1983 Jul; 224(2):568-78. PubMed ID: 6191666
[TBL] [Abstract][Full Text] [Related]
18. Catalytic properties of NAD(P)H:quinone acceptor oxidoreductase: study involving mouse, rat, human, and mouse-rat chimeric enzymes.
Chen S; Knox R; Lewis AD; Friedlos F; Workman P; Deng PS; Fung M; Ebenstein D; Wu K; Tsai TM
Mol Pharmacol; 1995 May; 47(5):934-9. PubMed ID: 7746280
[TBL] [Abstract][Full Text] [Related]
19. Caffeine, aminoimidazolecarboxamide and dicoumarol, inhibitors of NAD(P)H dehydrogenase (quinone) (DT diaphorase), prevent both the cytotoxicity and DNA interstrand crosslinking produced by 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB 1954) in Walker cells.
Roberts JJ; Marchbank T; Kotsaki-Kovatsi VP; Boland MP; Friedlos F; Knox RJ
Biochem Pharmacol; 1989 Nov; 38(22):4137-43. PubMed ID: 2480794
[TBL] [Abstract][Full Text] [Related]
20. Purification and characterization of an intracellular NADH: quinone reductase from Trametes versicolor.
Lee SS; Moon DS; Choi HT; Song HG
J Microbiol; 2007 Aug; 45(4):333-8. PubMed ID: 17846587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
